nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Seasonal allergy—Metformin—metabolic syndrome X	0.0731	0.0752	CcSEcCtD
Gabapentin—Function kidney decreased—Metformin—metabolic syndrome X	0.0702	0.0721	CcSEcCtD
Gabapentin—Rhinitis seasonal—Metformin—metabolic syndrome X	0.0702	0.0721	CcSEcCtD
Gabapentin—Viral diarrhoea—Metformin—metabolic syndrome X	0.0587	0.0603	CcSEcCtD
Gabapentin—Abnormal faeces—Metformin—metabolic syndrome X	0.0536	0.0551	CcSEcCtD
Gabapentin—Tooth abscess—Metformin—metabolic syndrome X	0.0367	0.0377	CcSEcCtD
Gabapentin—Nail disorder—Metformin—metabolic syndrome X	0.0236	0.0243	CcSEcCtD
Gabapentin—Contusion—Metformin—metabolic syndrome X	0.0176	0.0181	CcSEcCtD
Gabapentin—Accidental injury—Metformin—metabolic syndrome X	0.0173	0.0178	CcSEcCtD
Gabapentin—Neuropathy—Metformin—metabolic syndrome X	0.0144	0.0148	CcSEcCtD
Gabapentin—Ear pain—Metformin—metabolic syndrome X	0.013	0.0134	CcSEcCtD
Gabapentin—Injury—Metformin—metabolic syndrome X	0.0121	0.0124	CcSEcCtD
Gabapentin—Renal impairment—Metformin—metabolic syndrome X	0.0117	0.012	CcSEcCtD
Gabapentin—Hypoglycaemia—Metformin—metabolic syndrome X	0.0114	0.0117	CcSEcCtD
Gabapentin—Lethargy—Metformin—metabolic syndrome X	0.0114	0.0117	CcSEcCtD
Gabapentin—Pain in extremity—Metformin—metabolic syndrome X	0.0111	0.0114	CcSEcCtD
Gabapentin—Migraine—Metformin—metabolic syndrome X	0.0109	0.0113	CcSEcCtD
Gabapentin—Dehydration—Metformin—metabolic syndrome X	0.0103	0.0106	CcSEcCtD
Gabapentin—Liver function test abnormal—Metformin—metabolic syndrome X	0.0103	0.0106	CcSEcCtD
Gabapentin—Breast disorder—Metformin—metabolic syndrome X	0.0101	0.0103	CcSEcCtD
Gabapentin—Nasopharyngitis—Metformin—metabolic syndrome X	0.00995	0.0102	CcSEcCtD
Gabapentin—Influenza—Metformin—metabolic syndrome X	0.00961	0.00988	CcSEcCtD
Gabapentin—Pancreatitis—Metformin—metabolic syndrome X	0.00943	0.00969	CcSEcCtD
Gabapentin—Sweating increased—Metformin—metabolic syndrome X	0.00936	0.00963	CcSEcCtD
Gabapentin—Angina pectoris—Metformin—metabolic syndrome X	0.00936	0.00963	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00893	0.00918	CcSEcCtD
Gabapentin—Infestation—Metformin—metabolic syndrome X	0.00857	0.00881	CcSEcCtD
Gabapentin—Drowsiness—Metformin—metabolic syndrome X	0.00857	0.00881	CcSEcCtD
Gabapentin—Infestation NOS—Metformin—metabolic syndrome X	0.00857	0.00881	CcSEcCtD
Gabapentin—Neuropathy peripheral—Metformin—metabolic syndrome X	0.0084	0.00864	CcSEcCtD
Gabapentin—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00811	0.00833	CcSEcCtD
Gabapentin—Bradycardia—Metformin—metabolic syndrome X	0.00783	0.00805	CcSEcCtD
Gabapentin—Rhinitis—Metformin—metabolic syndrome X	0.00771	0.00793	CcSEcCtD
Gabapentin—Hepatitis—Metformin—metabolic syndrome X	0.00769	0.00791	CcSEcCtD
Gabapentin—Hypoaesthesia—Metformin—metabolic syndrome X	0.00766	0.00787	CcSEcCtD
Gabapentin—Oedema peripheral—Metformin—metabolic syndrome X	0.00758	0.00779	CcSEcCtD
Gabapentin—Connective tissue disorder—Metformin—metabolic syndrome X	0.00756	0.00777	CcSEcCtD
Gabapentin—Eye disorder—Metformin—metabolic syndrome X	0.00719	0.00739	CcSEcCtD
Gabapentin—Cardiac disorder—Metformin—metabolic syndrome X	0.00714	0.00734	CcSEcCtD
Gabapentin—Immune system disorder—Metformin—metabolic syndrome X	0.00695	0.00714	CcSEcCtD
Gabapentin—Mediastinal disorder—Metformin—metabolic syndrome X	0.00693	0.00713	CcSEcCtD
Gabapentin—Chills—Metformin—metabolic syndrome X	0.0069	0.0071	CcSEcCtD
Gabapentin—Malnutrition—Metformin—metabolic syndrome X	0.0067	0.00688	CcSEcCtD
Gabapentin—Erythema—Metformin—metabolic syndrome X	0.0067	0.00688	CcSEcCtD
Gabapentin—Flatulence—Metformin—metabolic syndrome X	0.0066	0.00678	CcSEcCtD
Gabapentin—Dysgeusia—Metformin—metabolic syndrome X	0.00656	0.00674	CcSEcCtD
Gabapentin—Muscle spasms—Metformin—metabolic syndrome X	0.00644	0.00662	CcSEcCtD
Gabapentin—Vision blurred—Metformin—metabolic syndrome X	0.00631	0.00649	CcSEcCtD
Gabapentin—Tremor—Metformin—metabolic syndrome X	0.00628	0.00645	CcSEcCtD
Gabapentin—Ill-defined disorder—Metformin—metabolic syndrome X	0.00622	0.00639	CcSEcCtD
Gabapentin—Malaise—Metformin—metabolic syndrome X	0.00604	0.00621	CcSEcCtD
Gabapentin—Syncope—Metformin—metabolic syndrome X	0.00601	0.00617	CcSEcCtD
Gabapentin—Palpitations—Metformin—metabolic syndrome X	0.00592	0.00608	CcSEcCtD
Gabapentin—Loss of consciousness—Metformin—metabolic syndrome X	0.00589	0.00605	CcSEcCtD
Gabapentin—Hypertension—Metformin—metabolic syndrome X	0.00578	0.00594	CcSEcCtD
Gabapentin—Chest pain—Metformin—metabolic syndrome X	0.0057	0.00586	CcSEcCtD
Gabapentin—Myalgia—Metformin—metabolic syndrome X	0.0057	0.00586	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00566	0.00582	CcSEcCtD
Gabapentin—Discomfort—Metformin—metabolic syndrome X	0.00563	0.00579	CcSEcCtD
Gabapentin—Oedema—Metformin—metabolic syndrome X	0.00547	0.00562	CcSEcCtD
Gabapentin—Infection—Metformin—metabolic syndrome X	0.00543	0.00558	CcSEcCtD
Gabapentin—Shock—Metformin—metabolic syndrome X	0.00538	0.00553	CcSEcCtD
Gabapentin—Nervous system disorder—Metformin—metabolic syndrome X	0.00536	0.00551	CcSEcCtD
Gabapentin—Thrombocytopenia—Metformin—metabolic syndrome X	0.00535	0.0055	CcSEcCtD
Gabapentin—Skin disorder—Metformin—metabolic syndrome X	0.00531	0.00546	CcSEcCtD
Gabapentin—Hyperhidrosis—Metformin—metabolic syndrome X	0.00529	0.00543	CcSEcCtD
Gabapentin—Anorexia—Metformin—metabolic syndrome X	0.00521	0.00536	CcSEcCtD
Gabapentin—Hypotension—Metformin—metabolic syndrome X	0.00511	0.00525	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00498	0.00512	CcSEcCtD
Gabapentin—Paraesthesia—Metformin—metabolic syndrome X	0.00491	0.00505	CcSEcCtD
Gabapentin—Dyspnoea—Metformin—metabolic syndrome X	0.00487	0.00501	CcSEcCtD
Gabapentin—Somnolence—Metformin—metabolic syndrome X	0.00486	0.005	CcSEcCtD
Gabapentin—Dyspepsia—Metformin—metabolic syndrome X	0.00481	0.00495	CcSEcCtD
Gabapentin—Decreased appetite—Metformin—metabolic syndrome X	0.00475	0.00488	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00472	0.00485	CcSEcCtD
Gabapentin—Fatigue—Metformin—metabolic syndrome X	0.00471	0.00484	CcSEcCtD
Gabapentin—Constipation—Metformin—metabolic syndrome X	0.00467	0.00481	CcSEcCtD
Gabapentin—Feeling abnormal—Metformin—metabolic syndrome X	0.00451	0.00463	CcSEcCtD
Gabapentin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00447	0.00459	CcSEcCtD
Gabapentin—Urticaria—Metformin—metabolic syndrome X	0.00434	0.00446	CcSEcCtD
Gabapentin—Abdominal pain—Metformin—metabolic syndrome X	0.00432	0.00444	CcSEcCtD
Gabapentin—Asthenia—Metformin—metabolic syndrome X	0.00392	0.00403	CcSEcCtD
Gabapentin—Pruritus—Metformin—metabolic syndrome X	0.00387	0.00398	CcSEcCtD
Gabapentin—Diarrhoea—Metformin—metabolic syndrome X	0.00374	0.00384	CcSEcCtD
Gabapentin—Dizziness—Metformin—metabolic syndrome X	0.00362	0.00372	CcSEcCtD
Gabapentin—Vomiting—Metformin—metabolic syndrome X	0.00348	0.00357	CcSEcCtD
Gabapentin—Rash—Metformin—metabolic syndrome X	0.00345	0.00354	CcSEcCtD
Gabapentin—Dermatitis—Metformin—metabolic syndrome X	0.00344	0.00354	CcSEcCtD
Gabapentin—Headache—Metformin—metabolic syndrome X	0.00342	0.00352	CcSEcCtD
Gabapentin—Nausea—Metformin—metabolic syndrome X	0.00325	0.00334	CcSEcCtD
Gabapentin—CACNA2D2—Integration of energy metabolism—MLXIPL—metabolic syndrome X	0.00177	0.0653	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—HMGA1—metabolic syndrome X	0.0017	0.0629	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—GOT2—metabolic syndrome X	0.000812	0.03	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NR1H3—metabolic syndrome X	0.000767	0.0283	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—GOT1—metabolic syndrome X	0.000701	0.0259	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—INS—metabolic syndrome X	0.000503	0.0186	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—HDAC3—metabolic syndrome X	0.000488	0.018	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—MTNR1B—metabolic syndrome X	0.000437	0.0161	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—INS—metabolic syndrome X	0.000396	0.0146	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	0.000385	0.0142	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NAMPT—metabolic syndrome X	0.000382	0.0141	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—FMO3—metabolic syndrome X	0.000374	0.0138	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.000357	0.0132	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SREBF1—metabolic syndrome X	0.00034	0.0126	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MLXIPL—metabolic syndrome X	0.000334	0.0123	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—EPHX2—metabolic syndrome X	0.000334	0.0123	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—GHRL—metabolic syndrome X	0.000322	0.0119	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—G6PC2—metabolic syndrome X	0.000314	0.0116	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—ADIPOQ—metabolic syndrome X	0.000312	0.0115	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000306	0.0113	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000279	0.0103	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CNR1—metabolic syndrome X	0.000269	0.00995	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—FABP4—metabolic syndrome X	0.000267	0.00985	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HSD11B1—metabolic syndrome X	0.000253	0.00934	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00025	0.00923	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SIRT1—metabolic syndrome X	0.000246	0.00908	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000239	0.00881	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000233	0.00861	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FMO3—metabolic syndrome X	0.000227	0.00838	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000226	0.00835	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—G6PD—metabolic syndrome X	0.000225	0.00832	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HDAC3—metabolic syndrome X	0.00022	0.00812	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPA—metabolic syndrome X	0.000215	0.00794	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GCKR—metabolic syndrome X	0.000215	0.00794	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000214	0.00791	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000209	0.00771	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLA2G6—metabolic syndrome X	0.000208	0.00769	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA5—metabolic syndrome X	0.000206	0.00761	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARA—metabolic syndrome X	0.000204	0.00755	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MLXIPL—metabolic syndrome X	0.000202	0.00747	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—EPHX2—metabolic syndrome X	0.000202	0.00747	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—LEP—metabolic syndrome X	0.000194	0.00716	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TRIB3—metabolic syndrome X	0.000192	0.00708	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—G6PC2—metabolic syndrome X	0.00019	0.00702	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000182	0.00671	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000175	0.00645	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GHRL—metabolic syndrome X	0.000172	0.00636	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NAMPT—metabolic syndrome X	0.000172	0.00635	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LIPC—metabolic syndrome X	0.000171	0.00631	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GCK—metabolic syndrome X	0.000171	0.00631	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOC3—metabolic syndrome X	0.00017	0.00627	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—metabolic syndrome X	0.000169	0.00624	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000166	0.00613	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CETP—metabolic syndrome X	0.000165	0.00609	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CNR1—metabolic syndrome X	0.000163	0.00602	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FABP4—metabolic syndrome X	0.000162	0.00597	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SCARB1—metabolic syndrome X	0.000158	0.00583	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD11B1—metabolic syndrome X	0.000153	0.00566	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SREBF1—metabolic syndrome X	0.000153	0.00566	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SERPINE1—metabolic syndrome X	0.000152	0.00562	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMGCR—metabolic syndrome X	0.000149	0.0055	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GOT2—metabolic syndrome X	0.000149	0.0055	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000139	0.00513	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—G6PD—metabolic syndrome X	0.000137	0.00504	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HDAC3—metabolic syndrome X	0.000133	0.00492	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC2A4—metabolic syndrome X	0.000133	0.00491	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCA1—metabolic syndrome X	0.000133	0.00491	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000132	0.00487	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCKR—metabolic syndrome X	0.00013	0.00481	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPA—metabolic syndrome X	0.00013	0.00481	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GGT1—metabolic syndrome X	0.000129	0.00475	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GOT1—metabolic syndrome X	0.000129	0.00475	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000126	0.00467	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLA2G6—metabolic syndrome X	0.000126	0.00466	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA5—metabolic syndrome X	0.000125	0.00461	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00012	0.00442	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TRIB3—metabolic syndrome X	0.000116	0.00429	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000114	0.00422	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOB—metabolic syndrome X	0.000109	0.00403	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLA2G4A—metabolic syndrome X	0.000106	0.00392	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AGT—metabolic syndrome X	0.000106	0.00391	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPL—metabolic syndrome X	0.000104	0.00385	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NAMPT—metabolic syndrome X	0.000104	0.00385	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LIPC—metabolic syndrome X	0.000103	0.00382	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCK—metabolic syndrome X	0.000103	0.00382	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOC3—metabolic syndrome X	0.000103	0.0038	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000103	0.00379	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CETP—metabolic syndrome X	9.99e-05	0.00369	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CD36—metabolic syndrome X	9.91e-05	0.00366	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GHRL—metabolic syndrome X	9.73e-05	0.00359	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SCARB1—metabolic syndrome X	9.56e-05	0.00353	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HTR2C—metabolic syndrome X	9.32e-05	0.00344	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SREBF1—metabolic syndrome X	9.28e-05	0.00343	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CNR1—metabolic syndrome X	9.22e-05	0.0034	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARA—metabolic syndrome X	9.21e-05	0.0034	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMGCR—metabolic syndrome X	9.03e-05	0.00333	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT2—metabolic syndrome X	9.03e-05	0.00333	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AGT—metabolic syndrome X	8.92e-05	0.00329	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GHRL—metabolic syndrome X	8.84e-05	0.00326	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOE—metabolic syndrome X	8.74e-05	0.00323	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—metabolic syndrome X	8.71e-05	0.00322	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA1—metabolic syndrome X	8.64e-05	0.00319	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CNR1—metabolic syndrome X	8.37e-05	0.00309	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCA1—metabolic syndrome X	8.05e-05	0.00297	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A4—metabolic syndrome X	8.05e-05	0.00297	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC3—metabolic syndrome X	7.91e-05	0.00292	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GGT1—metabolic syndrome X	7.8e-05	0.00288	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT1—metabolic syndrome X	7.8e-05	0.00288	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—metabolic syndrome X	7.61e-05	0.00281	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—INS—metabolic syndrome X	7.47e-05	0.00276	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—metabolic syndrome X	7.24e-05	0.00267	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCL5—metabolic syndrome X	7.14e-05	0.00264	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTNR1B—metabolic syndrome X	7.07e-05	0.00261	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RBP4—metabolic syndrome X	6.89e-05	0.00254	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TRIB3—metabolic syndrome X	6.89e-05	0.00254	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—metabolic syndrome X	6.84e-05	0.00253	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOB—metabolic syndrome X	6.61e-05	0.00244	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—metabolic syndrome X	6.55e-05	0.00242	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL5—metabolic syndrome X	6.49e-05	0.0024	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	6.46e-05	0.00239	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLA2G4A—metabolic syndrome X	6.43e-05	0.00238	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPL—metabolic syndrome X	6.32e-05	0.00233	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOC3—metabolic syndrome X	6.1e-05	0.00225	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CD36—metabolic syndrome X	6e-05	0.00222	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—metabolic syndrome X	5.99e-05	0.00221	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGT—metabolic syndrome X	5.98e-05	0.00221	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARA—metabolic syndrome X	5.58e-05	0.00206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR2C—metabolic syndrome X	5.51e-05	0.00203	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGT—metabolic syndrome X	5.43e-05	0.002	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AGT—metabolic syndrome X	5.4e-05	0.002	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CYBA—metabolic syndrome X	5.33e-05	0.00197	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—metabolic syndrome X	5.29e-05	0.00195	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA1—metabolic syndrome X	5.23e-05	0.00193	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GHRL—metabolic syndrome X	5.22e-05	0.00193	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CNR1—metabolic syndrome X	4.95e-05	0.00183	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—metabolic syndrome X	4.61e-05	0.0017	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INS—metabolic syndrome X	4.52e-05	0.00167	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—metabolic syndrome X	4.47e-05	0.00165	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—metabolic syndrome X	4.15e-05	0.00153	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF2—metabolic syndrome X	4.04e-05	0.00149	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—metabolic syndrome X	3.97e-05	0.00146	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOB—metabolic syndrome X	3.93e-05	0.00145	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL5—metabolic syndrome X	3.83e-05	0.00142	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLA2G4A—metabolic syndrome X	3.82e-05	0.00141	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPL—metabolic syndrome X	3.75e-05	0.00138	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—metabolic syndrome X	3.63e-05	0.00134	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGT—metabolic syndrome X	3.21e-05	0.00118	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—metabolic syndrome X	3.14e-05	0.00116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—metabolic syndrome X	3.14e-05	0.00116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA1—metabolic syndrome X	3.11e-05	0.00115	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—metabolic syndrome X	3.01e-05	0.00111	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS1—metabolic syndrome X	2.8e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INS—metabolic syndrome X	2.68e-05	0.000991	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL2—metabolic syndrome X	2.64e-05	0.000975	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—metabolic syndrome X	2.6e-05	0.000959	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—metabolic syndrome X	2.47e-05	0.00091	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—metabolic syndrome X	2.35e-05	0.000869	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—metabolic syndrome X	2.02e-05	0.000745	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—metabolic syndrome X	1.99e-05	0.000733	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—metabolic syndrome X	1.83e-05	0.000676	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—metabolic syndrome X	1.82e-05	0.000673	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—metabolic syndrome X	1.56e-05	0.000575	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—metabolic syndrome X	1.17e-05	0.000433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—metabolic syndrome X	1.08e-05	0.000399	CbGpPWpGaD
